Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding 1 1Edited by J. Doudna
- 1 January 2002
- journal article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 315 (4), 573-586
- https://doi.org/10.1006/jmbi.2001.5291
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.The Journal of Infectious Diseases, 1997
- Evaluation of Retinal Toxicity and Efficacy of Anti‐Cytomegalovirus and Anti‐Herpes Simplex Virus Antiviral Phosphorothioate Oligonucleotides ISIS 2922 and ISIS 4015The Journal of Infectious Diseases, 1997
- Trends in Infectious Diseases and Cancers among Persons Dying of HIV Infection in the United States from 1987 to 1992Annals of Internal Medicine, 1995
- Antiviral activity of a phosphorothioate oligonucleotide complementary to human cytomegalovirus RNA when used in combination with antiviral nucleoside analogsAntiviral Research, 1995
- Incidence and Natural History of Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Disease Treated with ZidovudineThe Journal of Infectious Diseases, 1992
- The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody StatusNew England Journal of Medicine, 1992
- A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDSAnnals of Internal Medicine, 1991
- Foscarnet Therapy for Ganciclovir-Resistant Cytomegalovirus Retinitis in Patients with AIDSThe Journal of Infectious Diseases, 1991
- Cytomegalovirus Retinitis and Response to Therapy with GanciclovirOphthalmology, 1987